13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-006071-12-IT
(EUCTR)
31/08/200509/05/2006Evaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine Vitamin B12 plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treatment with Nterferon beta over a period of 24 months for a better lonterm outComE - ADVANCEEvaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine Vitamin B12 plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treatment with Nterferon beta over a period of 24 months for a better lonterm outComE - ADVANCE MULTIPLE SCLEROSIS
MedDRA version: 6.1;Level: PT;Classification code 10028245
Trade Name: EPARMEFOLIN 30 CPR 0,1/0,5MG
INN or Proposed INN: CALCIO FOLINATO DC.IT
INN or Proposed INN: CIANOCOBALAMINA FU DC.IT
Trade Name: LEVOFOLENE 4 MG 30 CPR
INN or Proposed INN: Calcium levofolinate
AZIENDA OSPEDALIERA SAN CAMILLO FORLANININULLNot RecruitingFemale: yes
Male: yes
276Italy